share_log

睿昂基因(688217.SH):前三季度净利润572.73万元 同比减少69.58%

Ruiai Gene (688217.SH): The net income for the first three quarters was 5.7273 million yuan, a decrease of 69.58% year-on-year.

Gelonghui Finance ·  Oct 29, 2024 22:41

On October 29, Genor Biopharma (688217.SH) announced that in the first three quarters of 2024, it achieved revenue of 0.19 billion yuan, a decrease of 4.62% year-on-year; net income attributable to shareholders of the listed company was 5.7273 million yuan, down 69.58% year-on-year; basic earnings per share was 0.10 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment